Open AccessEfficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial
Author(s) -
Taciana Duque de Almeida Braga,
Giselia Alves Pontes da Silva,
Pedro Israel Cabral de Lira,
Marília de Carvalho Lima
Publication year - 2010
Publication title -
american journal of clinical nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.608
H-Index - 336
eISSN - 1938-3207
pISSN - 0002-9165
DOI - 10.3945/ajcn.2010.29799
Subject(s) - necrotizing enterocolitis , bifidobacterium breve , medicine , randomized controlled trial , probiotic , lactobacillus casei , bifidobacterium , enterocolitis , low birth weight , birth weight , gastroenterology , pediatrics , pregnancy , lactobacillus , biology , food science , bacteria , fermentation , genetics
Probiotics are used for the prevention of necrotizing enterocolitis (NEC) because of their positive effects on intestinal motor function, modulation of inflammatory response, and mucosal barrier function.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom